Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Loeb

Showing results (61-70 of 113) with videos related to

Pageof 12
Sort By:
Plos One|November 19, 2010
High ALDH activity identifies chemotherapy-resistant Ewing's sarcoma stem cells that retain sensitivity to EWS-FLI1 inhibitionOla Awad, Jason T Yustein, Preeti Shah, et al.
Frontiers in Oncology|April 19, 2013
LGR5 is Expressed by Ewing Sarcoma and Potentiates Wnt/β-Catenin SignalingChristopher A Scannell, Elisabeth A Pedersen, Jack T Mosher, et al.
Cancer|April 2, 2009
Dose-finding study of 153Sm-EDTMP in patients with poor-prognosis osteosarcomaDavid M Loeb, Elizabeth Garrett-Mayer, Robert F Hobbs, et al.
The Journal of Surgical Research|May 12, 2012
Epithelioid sarcoma: one institution's experience with a rare sarcomaAngela A Guzzetta, Elizabeth A Montgomery, Heather Lyu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 1, 2014
Feasibility of treating post-transplantation minimal residual disease in children with acute leukemiaNirali N Shah, Michael J Borowitz, Nancy C Robey, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 17, 2016
Induction of Immune Response after Allogeneic Wilms' Tumor 1 Dendritic Cell Vaccination and Donor Lymphocyte Infusion in Patients with Hematologic Malignancies and Post-Transplantation RelapseNirali N Shah, David M Loeb, Hahn Khuu, et al.
International Journal of Radiation Oncology, Biology, Physics|October 19, 2010
A treatment planning method for sequentially combining radiopharmaceutical therapy and external radiation therapyRobert F Hobbs, Todd McNutt, Sébastien Baechler, et al.
Plos Genetics|January 24, 2014
Cell-cycle dependent expression of a translocation-mediated fusion oncogene mediates checkpoint adaptation in rhabdomyosarcomaKen Kikuchi, Simone Hettmer, M Imran Aslam, et al.
Pediatric Blood & Cancer|July 21, 2009
WT1 expression at diagnosis does not predict survival in pediatric AML: a report from the Children's Oncology GroupSuzie A Noronha, Jason E Farrar, Todd A Alonzo, et al.
Translational Oncology|May 11, 2021
XPO1 inhibition with selinexor synergizes with proteasome inhibition in neuroblastoma by targeting nuclear export of IkBBasia Galinski, Marcus Luxemburg, Yosef Landesman, et al.
Pageof 12

Showing results (61-70 of 113) with videos related to

Sort By:
Pageof 12
Plos One|November 19, 2010
High ALDH activity identifies chemotherapy-resistant Ewing's sarcoma stem cells that retain sensitivity to EWS-FLI1 inhibitionOla Awad, Jason T Yustein, Preeti Shah, et al.
Frontiers in Oncology|April 19, 2013
LGR5 is Expressed by Ewing Sarcoma and Potentiates Wnt/β-Catenin SignalingChristopher A Scannell, Elisabeth A Pedersen, Jack T Mosher, et al.
Cancer|April 2, 2009
Dose-finding study of 153Sm-EDTMP in patients with poor-prognosis osteosarcomaDavid M Loeb, Elizabeth Garrett-Mayer, Robert F Hobbs, et al.
The Journal of Surgical Research|May 12, 2012
Epithelioid sarcoma: one institution's experience with a rare sarcomaAngela A Guzzetta, Elizabeth A Montgomery, Heather Lyu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 1, 2014
Feasibility of treating post-transplantation minimal residual disease in children with acute leukemiaNirali N Shah, Michael J Borowitz, Nancy C Robey, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 17, 2016
Induction of Immune Response after Allogeneic Wilms' Tumor 1 Dendritic Cell Vaccination and Donor Lymphocyte Infusion in Patients with Hematologic Malignancies and Post-Transplantation RelapseNirali N Shah, David M Loeb, Hahn Khuu, et al.
International Journal of Radiation Oncology, Biology, Physics|October 19, 2010
A treatment planning method for sequentially combining radiopharmaceutical therapy and external radiation therapyRobert F Hobbs, Todd McNutt, Sébastien Baechler, et al.
Plos Genetics|January 24, 2014
Cell-cycle dependent expression of a translocation-mediated fusion oncogene mediates checkpoint adaptation in rhabdomyosarcomaKen Kikuchi, Simone Hettmer, M Imran Aslam, et al.
Pediatric Blood & Cancer|July 21, 2009
WT1 expression at diagnosis does not predict survival in pediatric AML: a report from the Children's Oncology GroupSuzie A Noronha, Jason E Farrar, Todd A Alonzo, et al.
Translational Oncology|May 11, 2021
XPO1 inhibition with selinexor synergizes with proteasome inhibition in neuroblastoma by targeting nuclear export of IkBBasia Galinski, Marcus Luxemburg, Yosef Landesman, et al.
Pageof 12